文献速递眼底病与葡萄膜炎

烟酰胺单核苷酸减轻炎症激活、脉络膜新生血管及病灶相关重塑

Nicotinamide Mononucleotide Attenuates Inflammatory Activation, Choroidal Neovascularization, and Lesion-Associated Remodeling.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究在小鼠激光诱导脉络膜新生血管(CNV)模型中评估烟酰胺单核苷酸(NMN)的治疗潜力,发现NMN显著减小CNV面积、减少髓系细胞聚集,并抑制炎症、血管生成及纤维化相关重塑;体外实验进一步显示NMN抑制NF-κB激活及促纤维化反应。

要点

  • NMN在激光诱导CNV小鼠模型中显著减小CNV病灶面积。
  • NMN减少CNV病灶内髓系细胞聚集并抑制炎症/血管生成基因表达。
  • NMN减轻胶原I、F4/80及α-SMA阳性面积,提示抗重塑作用。

核心结论

  • NMN减轻CNV炎症信号与炎症微环境,并伴随血管生成相关基因表达和纤维化重塑减少。
  • NMN作为限制CNV进展及晚期组织重塑的辅助方法值得进一步评估。

研究设计与样本

  • 在C57BL/6J小鼠建立激光诱导CNV模型,以RPE/脉络膜铺片定量CNV病灶大小。
  • 采用免疫染色评估髓系细胞聚集与纤维化相关重塑,qRT-PCR和Western blot检测视网膜及RPE/脉络膜炎症/血管生成基因表达与信号激活。
  • 体外使用LPS刺激的bEnd.3细胞和原代小鼠RPE细胞,以及TGF-β刺激的THP-1来源巨噬细胞建模炎症与促纤维化反应。

主要发现

  • NMN治疗显著减小激光诱导CNV模型的CNV大小。
  • NMN减少CNV病灶内髓系细胞聚集。
  • NMN降低RPE/脉络膜和神经视网膜中炎症及血管生成相关基因表达,并减少下游信号激活。
  • 体外NMN抑制LPS诱导的原代RPE细胞和bEnd.3内皮细胞炎症及促血管生成反应,并抑制NF-κB激活。
  • 延长及延迟给药方案下NMN减少胶原I阳性面积,并减少CNV病灶内F4/80阳性面积和α-平滑肌肌动蛋白阳性面积;在TGF-β诱导的THP-1来源巨噬细胞中抑制促纤维化反应。

临床怎么用

  • 当前证据来自动物模型和体外细胞实验,尚不能直接转化为nAMD临床治疗方案。
  • NMN可能作为辅助策略限制CNV进展及晚期纤维化重塑,但需进一步临床评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the therapeutic potential of nicotinamide mononucleotide (NMN) for modulating the neurovascular inflammatory microenvironment and blunting tissue remodeling in neovascular age-related macular degeneration (nAMD). METHODS: A laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts. Immunostaining evaluated myeloid cell accumulation and fibrosis-associated remodeling. Quantitative RT-PCR and Western blotting assessed inflammatory/angiogenic gene expression and signaling activation in the retina and RPE/choroid. In vitro, lipopolysaccharide (LPS)-stimulated bEnd.3 and primary mouse RPE cells and TGF-β-stimulated THP-1-derived macrophage cells were used to model inflammatory and profibrotic responses. RESULTS: NMN treatment significantly reduced CNV size in the laser-induced CNV model. This was accompanied by decreased myeloid cell accumulation within CNV lesions. NMN attenuated inflammatory and angiogenesis-related gene expression in the RPE/choroid and neural retina and reduced downstream signaling activation. In vitro, NMN suppressed LPS-induced inflammatory and proangiogenic responses in primary RPE cells and bEnd.3 endothelial cells and inhibited NF-κB activation. NMN further attenuated tissue remodeling, as shown by reduced collagen I-positive area under prolonged and delayed dosing regimens, together with decreased F4/80-positive area and α-smooth muscle actin-positive area within CNV lesions. In TGF-β-induced THP-1-derived macrophage cells, NMN suppressed profibrotic responses. CONCLUSIONS: Our findings indicate that NMN reduces inflammatory signaling and alleviates the inflammatory microenvironment in CNV, accompanied by decreased angiogenesis-related gene expression and fibrosis-related remodeling. By attenuating inflammatory activation and tissue remodeling processes, NMN warrants further evaluation as an adjunctive approach to limit CNV progression and late-stage tissue remodeling in nAMD.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Wang J, Osada H, Chen S, et al. Nicotinamide Mononucleotide Attenuates Inflammatory Activation, Choroidal Neovascularization, and Lesion-Associated Remodeling. Invest Ophthalmol Vis Sci. 2026. PMID: 42640154. doi:10.1167/iovs.67.10.59

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。